1. Home
  2. ATXS vs INOD Comparison

ATXS vs INOD Comparison

Compare ATXS & INOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATXS
  • INOD
  • Stock Information
  • Founded
  • ATXS 2008
  • INOD 1988
  • Country
  • ATXS United States
  • INOD United States
  • Employees
  • ATXS N/A
  • INOD N/A
  • Industry
  • ATXS Biotechnology: Pharmaceutical Preparations
  • INOD EDP Services
  • Sector
  • ATXS Health Care
  • INOD Technology
  • Exchange
  • ATXS Nasdaq
  • INOD Nasdaq
  • Market Cap
  • ATXS 669.8M
  • INOD 623.4M
  • IPO Year
  • ATXS 2015
  • INOD 1993
  • Fundamental
  • Price
  • ATXS $9.37
  • INOD $36.75
  • Analyst Decision
  • ATXS Strong Buy
  • INOD Strong Buy
  • Analyst Count
  • ATXS 5
  • INOD 3
  • Target Price
  • ATXS $25.60
  • INOD $32.67
  • AVG Volume (30 Days)
  • ATXS 219.2K
  • INOD 1.5M
  • Earning Date
  • ATXS 11-13-2024
  • INOD 11-07-2024
  • Dividend Yield
  • ATXS N/A
  • INOD N/A
  • EPS Growth
  • ATXS N/A
  • INOD N/A
  • EPS
  • ATXS N/A
  • INOD 0.62
  • Revenue
  • ATXS N/A
  • INOD $137,393,000.00
  • Revenue This Year
  • ATXS N/A
  • INOD $61.58
  • Revenue Next Year
  • ATXS N/A
  • INOD $29.95
  • P/E Ratio
  • ATXS N/A
  • INOD $59.14
  • Revenue Growth
  • ATXS N/A
  • INOD 71.66
  • 52 Week Low
  • ATXS $4.26
  • INOD $5.46
  • 52 Week High
  • ATXS $16.90
  • INOD $49.72
  • Technical
  • Relative Strength Index (RSI)
  • ATXS 30.44
  • INOD 66.87
  • Support Level
  • ATXS $11.40
  • INOD $20.22
  • Resistance Level
  • ATXS $11.75
  • INOD $49.72
  • Average True Range (ATR)
  • ATXS 0.75
  • INOD 3.73
  • MACD
  • ATXS -0.23
  • INOD 1.50
  • Stochastic Oscillator
  • ATXS 7.64
  • INOD 56.81

About ATXS Astria Therapeutics Inc.

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.

About INOD Innodata Inc.

Innodata Inc is a digital services and solutions company. It provides technology and services to information products and online retail destinations. The company has three operating segments: Digital data solutions, Synodex, and Agility. It serves publishers, media and information companies, digital retailers, banks, insurance companies, government agencies, and other industries. Geographically, it operates in the United States, United Kingdom, Netherlands, Canada, and Europe.

Share on Social Networks: